Elutia, Inc. (ELUT)
0.8908
+0.20
(+29.36%)
USD |
NASDAQ |
Jan 13, 16:00
0.8702
-0.02
(-2.31%)
After-Hours: 20:00
Elutia Research and Development Expense (Annual): 3.785M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp. | 1.615B |
| Teleflex, Inc. | 161.67M |
| Perspective Therapeutics, Inc. | 39.33M |
| InfuSystem Holdings, Inc. | -- |
| Xtant Medical Holdings, Inc. | 2.385M |